Clinical trials in Macedonia, The Former Yugoslav Republic of
82 studies list at least one site in Macedonia, The Former Yugoslav Republic of. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2025-04-08.
Most studied here
Who runs them
Novo Nordisk A/S (20) · Hoffmann-La Roche (14) · Bayer (6) · Pharming Technologies B.V. (3) · Gustave Roussy, Cancer Campus, Grand Paris (2) · International Atomic Energy Agency (2) · Meril Life Sciences Pvt. Ltd. (2) · Sanofi (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 82 — search for more.
- C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) AttacksCompletedNCT01397864
- Community-based Mental Health Care for People With Severe and Enduring Mental III Health ( RECOVER-E )Status unknownNCT03892473Not applicable
- Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid ArthritisCompletedNCT01911234Phase 2
- ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With AlirocumabCompletedNCT01663402Phase 3
- Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With NormoalbuminuriaCompletedNCT02040441Phase 2/3
- Prevention of Child Mental Health Problems in Southeastern EuropeCompletedNCT03552250Not applicable
- A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's LymphomaCompletedNCT01200758Phase 3
- A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPDCompletedNCT01946620Phase 3
- A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic SyndromeWithdrawnNCT03303313Phase 2
- BioMime Vs. Xience Randomised Control Clinical StudyStatus unknownNCT02112981Not applicable
- Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold SystemStatus unknownNCT02663323Not applicable
- Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01313676Phase 3
- Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER StudyCompletedNCT02828683Not applicable
- A Study of LY2127399 in Participants With Systemic Lupus ErythematosusCompletedNCT01196091Phase 3
- Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773CompletedNCT01395810Phase 3
- A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard ChemotherapyCompletedNCT00338286Phase 3
- OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump TherapyCompletedNCT01182493Not applicable
- An Observational Study of First-Line Maintenance Rituximab (MabThera/Rituxan) in Participants With Follicular Non-Hodgkin's LymphomaCompletedNCT01684865
- A Study of Vemurafenib in Participants With Metastatic MelanomaCompletedNCT01307397Phase 3
- A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 InhibitorCompletedNCT02247739Phase 2
- Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia BCompletedNCT01386528Phase 3
- Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B PatientsCompletedNCT01333111Phase 3
- Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015CompletedNCT00984126Phase 3
- A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid ArthritisCompletedNCT01007435Phase 3
- Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v.CompletedNCT00632125Phase 4
- An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving PegasysCompletedNCT01011738
- An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis CCompletedNCT01447446
- Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia ACompletedNCT01138501Phase 3
- Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 DiabetesCompletedNCT00435019Phase 3
- Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00518882Phase 3
- Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedNCT01074268Phase 3
- Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedNCT00343980Phase 3
- Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenCompletedNCT01165684Phase 4
- Comparison of NN1250 With Insulin Glargine in Type 2 DiabetesCompletedNCT01006291Phase 3
- A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth HormoneCompletedNCT00936403Phase 2
- Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLCCompletedNCT00806819Phase 3
- An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes MellitusCompletedNCT01542424
- Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 DiabetesCompletedNCT00312156Phase 3
- Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 DiabetesCompletedNCT00604396Phase 3
- Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 DiabetesCompletedNCT01486940Phase 3
- Comparison of Insulin Detemir With NPH Insulin in Type 1 DiabetesCompletedNCT00184665Phase 3
- Xarelto for VTE Prophylaxis After Hip or Knee ArthroplastyCompletedNCT00831714
- Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 DiabetesCompletedNCT00665093
- Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689CompletedNCT00623194Phase 3
- An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)CompletedNCT01344889
- BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.CompletedNCT00545779Phase 3
- CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.CompletedNCT00479739Phase 4
- A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin MonotherapyCompletedNCT00823992Phase 3
- A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any ProcedureCompletedNCT01241396
- PROPHESYS 1: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Virus (HCV)Treated With Pegasys (Peginterferon Alfa-2a)CompletedNCT01070550